Management of Resistance to EGFR Tyrosine Kinase Inhibitors

被引：0
|
作者：
Mitsudomi, Tetsuya [1 ]
机构：
[1] Kindai Univ, Fac Med, Thorac Surg, Sayama, Osaka, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
Adenocarcinoma; EGFR; Resistance; T790M;
D O I：
10.1016/j.jtho.2016.11.073
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SC04.02
引用
收藏
页码：S82 / S83
页数：2
相关论文
共 50 条
  • [21] Characterization of acquired receptor tyrosine-kinase fusions as mechanisms of resistance to EGFR tyrosine-kinase inhibitors
    Xu, Haiyuan
    Shen, Jinge
    Xiang, Jianxing
    Li, Haiyan
    Li, Bing
    Zhang, Tengfei
    Zhang, Lu
    Mao, Xinru
    Jian, Hong
    Shu, Yongqian
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 6343 - 6350
  • [22] Loss of DEPTOR increases resistance to EGFR tyrosine kinase inhibitors by upregulating EGFR and MAPK signaling
    Cowell, Catherine F.
    De Bruin, Elza C.
    Howell, Michael
    Downward, Julian
    CLINICAL CANCER RESEARCH, 2012, 18 (10)
  • [23] CtDNA assay to detect EGFR mutations and mechanisms of resistance to EGFR tyrosine kinase inhibitors.
    Bazhenova, Lyudmila
    Das, Satya
    Patel, Sandip Pravin
    Arnold, Lyle
    Singh, Veena M.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [24] Therapeutic Strategies Utilized in the Setting of Acquired Resistance to EGFR Tyrosine Kinase Inhibitors
    Yu, Helena A.
    Riely, Gregory J.
    Lovly, Christine M.
    CLINICAL CANCER RESEARCH, 2014, 20 (23) : 5898 - 5907
  • [25] A noninvasive system for monitoring resistance to EGFR tyrosine kinase inhibitors with plasma DNA
    Nakamura, T.
    Sueoka-Aragane, N.
    Iwanaga, K.
    Sato, A.
    Komiya, K.
    Abe, T.
    Ureshino, N.
    Hayashi, S.
    Sueoka, E.
    Kimura, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [26] EGFR tyrosine kinase inhibitors overcome resistance to chemotherapy in malignant pleural mesothelioma
    Staumont, Bernard
    Costa, Chrisostome
    Vandermeers, Fabian
    Sriramareddy, Sathya Neelature
    Mascaux, Celine
    Scherpereel, Arnaud
    Duysinx, Bernard
    Louis, Renaud
    Delvenne, Philippe
    Hubert, Pascale
    Willems, Luc
    CANCER RESEARCH, 2016, 76
  • [27] BRAF Fusion - Another Mechanism of Acquired Resistance to EGFR Tyrosine Kinase Inhibitors
    Mitsudomi, Tetsuya
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (05) : 764 - 765
  • [28] HGF-MET in Resistance to EGFR Tyrosine Kinase Inhibitors in Lung Cancer
    Yano, Seiji
    Wang, Wei
    Li, Qi
    Yamada, Tadaaki
    Takeuchi, Shinji
    Matsumoto, Kunio
    Nishioka, Yasuhiko
    Sone, Saburo
    CURRENT SIGNAL TRANSDUCTION THERAPY, 2011, 6 (02) : 228 - 233
  • [29] A Mini-Review on EGFR-Tyrosine Kinase Inhibitors and their Resistance Mechanisms
    Naim, Mohd. Javed
    Samad, Abdul
    CURRENT PHARMACEUTICAL DESIGN, 2025,
  • [30] Management of tyrosine kinase inhibitor resistance in lung cancer with EGFR mutation
    Becker, Kevin
    Xu, Yiqing
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2014, 5 (04): : 560 - 567
12345